Applied Dna Sciences Inc (BNBX)

$2.88 -0.24 (-7.56%)
Market Cap 14.55M
Revenue (ttm) 3.43M
Net Income (ttm) -6.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -203.79%
Debt to Equity Ratio 0.00
Volume 42,869
Avg Vol 1,690,958
Day's Range N/A - N/A
Shares Out 4.36M
Stochastic %K 6%
Beta 0.15
Analysts Hold
Price Target N/A

Company Profile

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics; and nucleic-acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as t...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 631 240 8800
Fax: 631 240 8900
Website: adnas.com
Address:
50 Health Sciences Drive, Stony Brook, United States
jeni1988
jeni1988 Nov. 13 at 10:10 PM
$BNBX Crypto recover will bust this so hard
0 · Reply
boomshiva
boomshiva Nov. 13 at 9:14 PM
$BNBX Slowly working its way down to sub-$3. Company might have picked the absolute worst time to go into crypto
1 · Reply
merlin8121
merlin8121 Nov. 13 at 6:31 PM
$BNBX comparative report for $BNBX and other tickers with catalysts and big short positions https://www.merlintrader.com/comparative-catalysts-and-trade-ideas/
0 · Reply
MarkWeir
MarkWeir Nov. 13 at 3:30 PM
$BNBX
0 · Reply
eatrader01
eatrader01 Nov. 13 at 2:47 PM
$BNBX
0 · Reply
InvincibleX
InvincibleX Nov. 13 at 11:32 AM
$BNBX I think It's a actually dead company that only need to avoid from delisting.
0 · Reply
eatrader01
eatrader01 Nov. 13 at 1:01 AM
$BNBX
0 · Reply
EAGonzalez
EAGonzalez Nov. 12 at 10:25 PM
$BNBX quiet, too quiet...
0 · Reply
Alfahker
Alfahker Nov. 12 at 1:33 AM
$BNBX
0 · Reply
MarkWeir
MarkWeir Nov. 11 at 9:15 PM
$BNBX …. Just a little bit every day ⬆️
0 · Reply
Latest News on BNBX
BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update

Oct 28, 2025, 8:00 AM EDT - 17 days ago

BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update

Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million

Oct 22, 2025, 8:00 AM EDT - 23 days ago

Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million

Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX' Reflecting Digital Asset Treasury Strategy

Oct 6, 2025, 8:00 AM EDT - 5 weeks ago

Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX' Reflecting Digital Asset Treasury Strategy

Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation

Sep 29, 2025, 3:08 PM EDT - 6 weeks ago

Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation

Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences

Sep 23, 2025, 8:30 AM EDT - 7 weeks ago

Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

Aug 14, 2025, 4:10 PM EDT - 3 months ago

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application

Jul 24, 2025, 9:00 AM EDT - 4 months ago

Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application

Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements

Jul 7, 2025, 9:00 AM EDT - 4 months ago

Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

Jun 30, 2025, 9:00 AM EDT - 4 months ago

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

Jun 17, 2025, 4:10 PM EDT - 5 months ago

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

Jun 16, 2025, 9:00 AM EDT - 5 months ago

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

May 29, 2025, 8:00 AM EDT - 6 months ago

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

May 15, 2025, 4:05 PM EDT - 6 months ago

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

May 14, 2025, 11:30 AM EDT - 6 months ago

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

Apr 21, 2025, 9:00 AM EDT - 7 months ago

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Apr 8, 2025, 9:00 AM EDT - 7 months ago

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

Apr 1, 2025, 9:45 AM EDT - 8 months ago

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

Mar 26, 2025, 9:00 AM EDT - 8 months ago

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

Mar 12, 2025, 8:00 AM EDT - 8 months ago

Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call Transcript

Feb 14, 2025, 2:10 PM EST - 9 months ago

Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call Transcript

Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

Feb 13, 2025, 4:03 PM EST - 9 months ago

Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

Feb 12, 2025, 12:00 PM EST - 9 months ago

Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14

Feb 11, 2025, 8:30 AM EST - 9 months ago

Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14

Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

Jan 10, 2025, 9:00 AM EST - 11 months ago

Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

Jan 8, 2025, 4:30 PM EST - 11 months ago

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

Dec 18, 2024, 9:00 AM EST - 11 months ago

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

Dec 17, 2024, 4:05 PM EST - 11 months ago

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

Dec 16, 2024, 10:00 AM EST - 11 months ago

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 30, 2024, 7:15 AM EDT - 1 year ago

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Oct 15, 2024, 10:30 AM EDT - 1 year ago

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit

Sep 17, 2024, 9:15 AM EDT - 1 year ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application

Sep 17, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application

Applied DNA Launches Mpox Clade I and Clade II Testing Service

Sep 11, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Launches Mpox Clade I and Clade II Testing Service

Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan

Sep 4, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan

Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?

Aug 23, 2024, 1:19 PM EDT - 1 year ago

Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

Aug 23, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I

Aug 19, 2024, 3:25 PM EDT - 1 year ago

Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I

Applied DNA Sciences, Inc. (APDN) Q3 2024 Earnings Call Transcript

Aug 11, 2024, 12:29 PM EDT - 1 year ago

Applied DNA Sciences, Inc. (APDN) Q3 2024 Earnings Call Transcript

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit

Jul 29, 2024, 11:57 AM EDT - 1 year ago

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit

Jul 29, 2024, 11:10 AM EDT - 1 year ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit

Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability

Jul 25, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability

U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract

Jul 18, 2024, 10:00 AM EDT - 1 year ago

U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

Jun 20, 2024, 9:15 AM EDT - 1 year ago

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

MRVI

Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing

Jun 18, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing

Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health

Jun 13, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health

Time to Play 5 Top-Ranked Stocks With Rising P/E?

Jun 10, 2024, 1:14 PM EDT - 1 year ago

Time to Play 5 Top-Ranked Stocks With Rising P/E?

AMC HCAT XGN YOU

Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform

Jun 5, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform

Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML

May 13, 2024, 8:55 AM EDT - 1 year ago

Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML

jeni1988
jeni1988 Nov. 13 at 10:10 PM
$BNBX Crypto recover will bust this so hard
0 · Reply
boomshiva
boomshiva Nov. 13 at 9:14 PM
$BNBX Slowly working its way down to sub-$3. Company might have picked the absolute worst time to go into crypto
1 · Reply
merlin8121
merlin8121 Nov. 13 at 6:31 PM
$BNBX comparative report for $BNBX and other tickers with catalysts and big short positions https://www.merlintrader.com/comparative-catalysts-and-trade-ideas/
0 · Reply
MarkWeir
MarkWeir Nov. 13 at 3:30 PM
$BNBX
0 · Reply
eatrader01
eatrader01 Nov. 13 at 2:47 PM
$BNBX
0 · Reply
InvincibleX
InvincibleX Nov. 13 at 11:32 AM
$BNBX I think It's a actually dead company that only need to avoid from delisting.
0 · Reply
eatrader01
eatrader01 Nov. 13 at 1:01 AM
$BNBX
0 · Reply
EAGonzalez
EAGonzalez Nov. 12 at 10:25 PM
$BNBX quiet, too quiet...
0 · Reply
Alfahker
Alfahker Nov. 12 at 1:33 AM
$BNBX
0 · Reply
MarkWeir
MarkWeir Nov. 11 at 9:15 PM
$BNBX …. Just a little bit every day ⬆️
0 · Reply
MarkWeir
MarkWeir Nov. 11 at 12:48 PM
$BNBX 🌞
0 · Reply
WilliamJ00s
WilliamJ00s Nov. 11 at 7:51 AM
$BNBX this could go the same way as $GLTO
0 · Reply
pi828
pi828 Nov. 10 at 4:53 PM
$BNBX Anthony screwed us royally. Thank-you.
0 · Reply
MarkWeir
MarkWeir Nov. 10 at 2:13 PM
$BNBX good morning 🌞
0 · Reply
HetroBabadook
HetroBabadook Nov. 7 at 3:29 AM
$BNBX This always makes me laugh when China bots try and pump garbage. 💥 This was a complete train wreck for many years and now that they changed the ticker it is supposed to be all better. 🤣 a picture of your future below. 💯 percent value....gone
0 · Reply
MarkWeir
MarkWeir Nov. 7 at 12:38 AM
$BNBX slowly, each day going up a little bit ⬆️ 
0 · Reply
Alfahker
Alfahker Nov. 6 at 11:11 PM
$BNBX
0 · Reply
10_100_1000
10_100_1000 Nov. 6 at 1:47 PM
$SLRX $TNGX $SNBR $SONN $BNBX GAMESQUARE = $ GAME 5 DAYS TO COVER https://fintel.io/ss/us/game
0 · Reply
MarkWeir
MarkWeir Nov. 6 at 12:58 PM
$BNBX
0 · Reply
Kikikikiii
Kikikikiii Nov. 5 at 7:45 PM
$BNBX with no paper flying a PR Will be a banger
1 · Reply
Kikikikiii
Kikikikiii Nov. 5 at 4:39 PM
$BNBX hope they are buying bnb in This dip
1 · Reply
MarkWeir
MarkWeir Nov. 5 at 1:41 PM
$BNBX
0 · Reply